James D Iii Rollins

Director James D Iii Rollins sold 223.5K HBAN shares at $17.35 for $3.9M, reducing holdings by -26.7%

Rollins sold 223,522 shares at $17.35 on 2026-06-12, the largest reduction in his HBAN holdings (-26.7% vs pre-transaction level), leaving him with 612,155 shares. This sale occurred just days after he executed four buy transactions at the same ticker (2026-06-02 through 2026-06-04), creating a contradictory trading sequence. His cross-ticker track record shows 14 prior buys with a 90-day win rate of 0.00% and average 90-day returns of -24.6%, while his sole measurable prior buy at HBAN (2026-04-28) declined -23.4% over 30 days. The current stock price of $17.32 sits -11.0% from the 52-week high of $19.46, despite recent 30-day and 90-day price appreciation of +12.4% and +14.6% respectively. The company's fundamentals remain solid with a P/E of 15.89 and annual revenue growth of +6.4%.

Director Rollins buys 22,000 shares of HBAN in 4 transactions totaling $401.2K at $18.24 blended average

James D Iii Rollins, a director of Huntington Bancshares, executed 4 separate purchases totaling 22,000 shares for $401.2K between June 2-4, 2026, at prices ranging from $16.46 to $20.35. His post-transaction holdings stand at 10,000 shares. However, his track record raises concerns about timing discipline: across his 5 prior trades at HBAN, his 90-day win rate is 0% (0 of 5 buys were followed by positive 90-day returns), with prior purchases suffering losses ranging from -6.2% to -37.3%. His cross-ticker track record similarly shows an average 90-day return of -23.6% across 10 buys, with a 0.00% win rate. The current price of $16.53 is -15.1% from the 52-week high and below his blended purchase price of $18.24, suggesting immediate mark-to-market underwater position. This purchase pattern, combined with the consistent historical underperformance of his prior HBAN acquisitions, merits observation but does not constitute a strong vote of confidence given the execution outcomes.

Director James D Rollins III purchases 11,500 shares of HBAN across three transactions, signaling confidence in fundamentally sound bank.

James D Rollins III, a board director with operational visibility into HBAN, made a substantial three-part open-market purchase totaling approximately 11,500 shares over two trading days. This comes while the stock trades noticeably below its recent highs, creating a technical setup where insider buying often signals confidence—Rollins is buying a pullback rather than chasing momentum. Huntington Bancshares is a profitable, revenue-growing bank trading at a reasonable valuation multiple, making it the type of fundamentally sound business that typically attracts insider accumulation. The clustering of purchases across consecutive days, rather than a single block trade, suggests deliberate accumulation by someone with board-level knowledge of the company's trajectory. While individual director purchases are routine, the scale and timing of this accumulation during a period of price weakness deserves attention from investors seeking to identify informed conviction among management.

Director James D Rollins III bought 1,212 shares at Huntington Bancshares (HBAN) across 3 trades (Mar 6–9) for $30,114.42; holdings grew 43.5% to 4,000 shares.

Director Rollins III completed 3 separate purchases totaling 1,212 shares for $30,114.42 between March 6 and March 9, 2026, raising his holdings from 2,788 shares to 4,000 shares, a net increase of +43.5%. The purchases occurred at prices ranging from $17.65 to $25.39, with a blended average of $24.85. The current price has since declined to $16.12, -16.4% from the 52-week high and representing a mark-to-market decline relative to the transaction average. His prior 4 trades at HBAN remain outcome-unmeasurable at the 90-day horizon. This filing represents accumulation activity by a director at a $32.7B market-cap bank with trailing quarterly net income of $629,000,000 and annual revenue growth of +6.4%.

Director Rollins buys 4,915 shares of HBAN at $17.65; stock now at $16.83, -12.7% from 52-week high

James D III Rollins, a Director, purchased 4,915 shares at $17.65 on 2026-03-03, establishing an initial position of 4,915 shares with a transaction value of $86,749.75. The purchase occurs within a period of intensifying buying activity: Rollins completed three separate purchases of HBAN stock on 2026-02-27 (two transactions) and 2026-03-02, indicating a deliberate accumulation pattern over consecutive trading days. The timing context is notable—the current price of $16.83 reflects a -12.7% decline from the 52-week high of $19.27 and a -5.9% decline over the past 30 days, suggesting the director was acquiring shares during a period of price weakness relative to recent peaks. HBAN fundamentals remain solid with annual revenue growth of 6.4%, a P/E of 13.68, and quarterly net income of $629,000,000, though the recent price action indicates near-term market headwinds or sector pressure.

Director James D Rollins III bought 7,373 shares for $170,616.74 across 3 transactions; stock now down 13.1% from 52-week high.

Director James D Rollins III executed 3 separate purchases totaling 7,373 shares for $170,616.74 at blended average price of $23.14 across February and March 2026. The current price of $16.75 sits 13.1% below the 52-week high of $19.27, indicating the stock has declined materially since his purchases. His post-transaction holdings stand at 4,500 shares. While the company shows solid fundamentals with $424.0M quarterly revenue, $629.0M net income, and a reasonable P/E of 13.62, the director's purchases occurred at meaningfully higher valuations than current levels, and his prior cross-ticker history shows only 1 prior buy with no established pattern. The timing of these purchases relative to the subsequent price weakness merits observation, though limited historical context at this ticker constrains broader pattern assessment.